<code id='B8C374FC5A'></code><style id='B8C374FC5A'></style>
    • <acronym id='B8C374FC5A'></acronym>
      <center id='B8C374FC5A'><center id='B8C374FC5A'><tfoot id='B8C374FC5A'></tfoot></center><abbr id='B8C374FC5A'><dir id='B8C374FC5A'><tfoot id='B8C374FC5A'></tfoot><noframes id='B8C374FC5A'>

    • <optgroup id='B8C374FC5A'><strike id='B8C374FC5A'><sup id='B8C374FC5A'></sup></strike><code id='B8C374FC5A'></code></optgroup>
        1. <b id='B8C374FC5A'><label id='B8C374FC5A'><select id='B8C374FC5A'><dt id='B8C374FC5A'><span id='B8C374FC5A'></span></dt></select></label></b><u id='B8C374FC5A'></u>
          <i id='B8C374FC5A'><strike id='B8C374FC5A'><tt id='B8C374FC5A'><pre id='B8C374FC5A'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:92
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers
          ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

          ANDREWYATES/AFPviaGettyImagesInpatientswithstage3lungcancerwhereaparticulargeneticmutationispresenti

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Ultragenyx gene therapy for rare liver ailment succeeds in late

          JonathanWiggs/GlobeStaffUltragenyxsaidThursdayafternoonthatitsgenetherapyforarareliverailment,glycog